• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease.

作者信息

Lomer M C, Harvey R S, Evans S M, Thompson R P, Powell J J

机构信息

Nutrition and Dietetic Department, The Rayne Institute, St Thomas' Hospital, London, UK.

出版信息

Eur J Gastroenterol Hepatol. 2001 Feb;13(2):101-6. doi: 10.1097/00042737-200102000-00003.

DOI:10.1097/00042737-200102000-00003
PMID:11246607
Abstract

BACKGROUND

Ultrafine and fine particles are potent adjuvants in antigen-mediated immune responses, and cause inflammation in susceptible individuals. Following recent findings that microparticles accumulate in the phagocytes of intestinal lymphoid aggregates, this study is the first investigation of whether their reduction in the diet improves the symptoms of Crohn's disease.

METHODS

In a double blind study, 20 patients with active corticosteroid-treated ileal or ileo-colonic Crohn's disease randomly received either a low microparticle diet (trial group; n = 10) or a control diet (n = 10) for 4 months. Crohn's disease activity index (CDAI) and corticosteroid requirements were compared.

RESULTS

One patient in each group was withdrawn. In the trial group there was a progressive decrease in CDAI from entry (392 +/- 25) to month 4 (145 +/- 47) (P = 0.002 vs control group) and seven patients were in remission (CDAI <150). In contrast, the control group had returned to baseline levels (302 +/- 28 on entry and 295 +/- 25 at month 4), with none in remission. Corticosteroid intake was reduced more in the trial group although this did not reach significance.

CONCLUSIONS

A low microparticle diet may be effective in the management of ileal Crohn's disease and could explain the efficacy of elemental diets, which similarly are low in microparticles.

摘要

相似文献

1
Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease.
Eur J Gastroenterol Hepatol. 2001 Feb;13(2):101-6. doi: 10.1097/00042737-200102000-00003.
2
Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease.饮食中的细颗粒和超细颗粒:对黏膜免疫反应的影响以及与克罗恩病的关联。
Proc Nutr Soc. 2002 Feb;61(1):123-30. doi: 10.1079/pns2001134.
3
Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease.
Eur J Gastroenterol Hepatol. 2005 Mar;17(3):377-84. doi: 10.1097/00042737-200503000-00019.
4
Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.美沙拉嗪(美沙拉嗪/艾迪莎)每日两次,每次1.5克,与安慰剂用于维持克罗恩病患者缓解状态的对比研究。
Aliment Pharmacol Ther. 1995 Dec;9(6):673-83. doi: 10.1111/j.1365-2036.1995.tb00438.x.
5
Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial.聚合物饮食与要素饮食作为活动性克罗恩病的初始治疗:一项随机双盲试验
Am J Gastroenterol. 2000 Mar;95(3):735-9. doi: 10.1111/j.1572-0241.2000.01527.x.
6
Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group.低剂量布地奈德治疗预防克罗恩病术后复发:一项多中心随机安慰剂对照试验。德国布地奈德研究组
Eur J Gastroenterol Hepatol. 1999 Mar;11(3):277-82. doi: 10.1097/00042737-199903000-00011.
7
A comparison of budesonide with prednisolone for active Crohn's disease.布地奈德与泼尼松龙治疗活动期克罗恩病的比较。
N Engl J Med. 1994 Sep 29;331(13):842-5. doi: 10.1056/NEJM199409293311304.
8
Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group.
Aliment Pharmacol Ther. 1998 Feb;12(2):175-83. doi: 10.1046/j.1365-2036.1998.00285.x.
9
Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.富含谷氨酰胺的聚合物饮食治疗活动期克罗恩病的双盲随机对照试验。
J Pediatr Gastroenterol Nutr. 2000 Jan;30(1):78-84. doi: 10.1097/00005176-200001000-00022.
10
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.一项比较要素饮食与类固醇治疗克罗恩病的随机对照研究。
Aliment Pharmacol Ther. 1997 Aug;11(4):735-40. doi: 10.1046/j.1365-2036.1997.t01-1-00192.x.

引用本文的文献

1
Ultra-processed foods: Implications for gastrointestinal health.超加工食品:对胃肠道健康的影响。
World J Gastroenterol. 2025 Sep 28;31(36):109143. doi: 10.3748/wjg.v31.i36.109143.
2
Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions.炎症性肠病的饮食干预与口服营养补充:当前证据与未来方向
Nutrients. 2025 May 30;17(11):1879. doi: 10.3390/nu17111879.
3
Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.
炎症性肠病患者食用食物污染物和药物的不良反应风险升高:综述
Arch Toxicol. 2024 Nov;98(11):3519-3541. doi: 10.1007/s00204-024-03844-w. Epub 2024 Sep 9.
4
Ultra-processed foods and food additives in gut health and disease.超加工食品和食品添加剂与肠道健康和疾病。
Nat Rev Gastroenterol Hepatol. 2024 Jun;21(6):406-427. doi: 10.1038/s41575-024-00893-5. Epub 2024 Feb 22.
5
Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts.饮食暴露与干预在炎症性肠病中的应用:当前证据和新兴概念。
Nutrients. 2023 Jan 22;15(3):579. doi: 10.3390/nu15030579.
6
Ultra-processed foods as a possible culprit for the rising prevalence of inflammatory bowel diseases.超加工食品可能是炎症性肠病患病率上升的罪魁祸首。
Front Med (Lausanne). 2022 Nov 7;9:1058373. doi: 10.3389/fmed.2022.1058373. eCollection 2022.
7
British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease.英国营养协会关于炎症性肠病患者营养评估和饮食管理的共识指南。
J Hum Nutr Diet. 2023 Feb;36(1):336-377. doi: 10.1111/jhn.13054. Epub 2022 Jul 21.
8
Current recommendations on the role of diet in the aetiology and management of IBD.关于饮食在炎症性肠病的病因学和管理中的作用的当前建议。
Frontline Gastroenterol. 2021 May 26;13(2):160-167. doi: 10.1136/flgastro-2020-101429. eCollection 2022.
9
Diets for inflammatory bowel disease: What do we know so far?炎症性肠病的饮食:我们目前了解多少?
Eur J Clin Nutr. 2022 Sep;76(9):1222-1233. doi: 10.1038/s41430-021-01051-9. Epub 2022 Jan 22.
10
The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review.饮食在炎症性肠病发病机制和治疗中的作用:综述。
Nutrients. 2020 Dec 31;13(1):135. doi: 10.3390/nu13010135.